DF
RPRX icon

Donoghue Forlines’s Royalty Pharma RPRX Stock Holding History

Donoghue Forlines’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-42,687
Closed -$1.21M – 247
2024
Q3 		$1.21M Buy
42,687
+20,211
+90% +$560K 0.34% 105
2024
Q2 		$593K Buy
22,476
+1,719
+8% +$47.7K 0.17% 139
2024
Q1 		$630K Buy
+20,757
New +$612K 0.18% 143
2023
Q3 		– Sell
-11,712
Closed -$360K – 279
2023
Q2 		$360K Sell
11,712
-6,723
-36% -$228K 0.11% 200
2023
Q1 		$664K Buy
18,435
+12,916
+234% +$479K 0.24% 114
2022
Q4 		$218K Sell
5,519
-1,037
-16% -$43.3K 0.08% 211
2022
Q3 		$263K Sell
6,556
-9,359
-59% -$400K 0.09% 187
2022
Q2 		$669K Buy
15,915
+3,133
+25% +$128K 0.17% 144
2022
Q1 		$498K Buy
+12,782
New +$502K 0.11% 250

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return